tiprankstipranks
Trending News
More News >
Maze Therapeutics, Inc. (MAZE)
:MAZE
US Market
Advertisement

Maze Therapeutics, Inc. (MAZE) Income Statement

Compare
27 Followers

Maze Therapeutics, Inc. Income Statement

Last quarter (Q2 2025), Maze Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Maze Therapeutics, Inc.'s net income was $-33.68M. See Maze Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 167.50M$ 0.00$ 0.00
Gross Profit
$ 167.50M$ -4.09M$ -3.82M
Operating Expenses
$ 109.91M$ 98.55M$ 111.03M
Depreciation and Amortization
$ 3.30M$ 4.09M$ 3.82M
EBITDA
$ 60.88M$ -94.46M$ -107.21M
Operating Income
$ 57.59M$ -98.55M$ -111.03M
Other Income/Expenses
$ -4.18M$ -1.86M$ -3.91M
Pretax Income
$ 53.40M$ -100.42M$ -114.94M
Net Income
$ 52.23M$ -100.42M$ -114.94M
Per Share Metrics
Basic EPS
$ 0.08$ -2.29$ -2.63
Diluted EPS
$ 0.08$ -2.29$ -2.63
Weighted Average Shares Outstanding
43.80M 43.78M 43.78M
Weighted Average Shares Outstanding (Diluted)
43.80M 43.78M 43.78M
Currency in USD

Maze Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis